Back
Aprea Therapeutics Vs. Brainstorm Cell Therapeutics Industry Stock Comparison
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
Sell
8
BCLI
Brainstorm Cell Therapeutics
Last Price:
2.23
Seasonality Move:
-7.58%
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy, Sell or Hold?
- The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- APRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $2.34. The Score for BCLI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APRE Stock Price Chart
What is Aprea Therapeutics's stock price today?
-
The Aprea Therapeutics share price today is $2.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APRE is experiencing selling pressure, which indicates risk of future bearish movement.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $2.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
APRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 33.15 | Sell |
Chaikin Money Flow: | -13903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.78 - 3.32) | Sell |
Bollinger Bands (100): | (3.14 - 4.58) | Sell |
BCLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.47 | Sell |
Relative Strength Index (14 RSI): | 24.28 | Sell |
Chaikin Money Flow: | -18150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.17 - 4.27) | Sell |
Bollinger Bands (100): | (3.91 - 6.79) | Sell |
APRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.73 | Sell |
20-day SMA: | 2.96 | Sell |
50-day SMA: | 3.31 | Sell |
200-day SMA: | 4.86 | Sell |
8-day EMA: | 2.74 | Sell |
20-day EMA: | 2.94 | Sell |
50-day EMA: | 3.3 | Sell |
200-day EMA: | 4.5 | Sell |
BCLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.15 | Sell |
20-day SMA: | 3.59 | Sell |
50-day SMA: | 4.27 | Sell |
200-day SMA: | 5.74 | Sell |
8-day EMA: | 3 | Sell |
20-day EMA: | 3.5 | Sell |
50-day EMA: | 4.22 | Sell |
200-day EMA: | 7.23 | Sell |
Aprea Therapeutics Earnings Growth & APRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $2.56 per share.
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.55 per share, and an increase next year of $0.08 per share.
Aprea Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Brainstorm Cell Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |